TegoSens
Columbus, US · Founded 2020 · Delaware corporation · 1 known investors
Tegosens is developing a non-invasive diagnostic solution for heart failure, aiming to address the high cost, invasiveness, and unreliability of existing diagnostic methods. The company targets a condition that affects over 60 million people globally.
Digital HealthHealthtechMedical Devices
Founders & leadership
AJ
Abraham JosephChief Executive Officer
DW
Dr. William AbrahamCo-Inventor & Lead Clinical Consultant
DE
Dr. Emre ErtinCo-Inventor & Director of Technology
AJ
Abe JosephCEO
Board
FL
Flavio LobatoBoard director
DM
David MoritzBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.9M disclosed across 1 round · 2021
▶$1.9MraisedAug 2024 · 32 investors · Other Health CareRule 506(b)
▶$1.9MraisedAug 2024 · 32 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Flavio LobatoDirector
- David MoritzDirector
- Abraham JosephExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.9M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does TegoSens do?
- Tegosens is developing a non-invasive diagnostic solution for heart failure, aiming to address the high cost, invasiveness, and unreliability of existing diagnostic methods. The company targets a condition that affects over 60 million people globally.
- Who are TegoSens's investors?
- TegoSens's investors include JumpStart Equity.
- How much funding has TegoSens raised?
- TegoSens has disclosed $1.9M raised across 1 round.
- Where is TegoSens headquartered?
- TegoSens is headquartered in Columbus, US.